Wealthcare Advisory Partners LLC Makes New $37,000 Investment in NeurAxis, Inc. $NRXS

Wealthcare Advisory Partners LLC bought a new position in shares of NeurAxis, Inc. (NASDAQ:NRXS) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 15,188 shares of the company’s stock, valued at approximately $37,000. Wealthcare Advisory Partners LLC owned about 0.21% of NeurAxis as of its most recent SEC filing.

Separately, AIGH Capital Management LLC bought a new position in NeurAxis during the 1st quarter worth approximately $43,000. 11.77% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on NeurAxis in a report on Monday, June 16th. They set a “buy” rating on the stock. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, NeurAxis has an average rating of “Buy” and a consensus price target of $7.00.

NeurAxis Trading Down 2.0%

Shares of NASDAQ NRXS opened at $2.98 on Friday. The company has a market cap of $29.42 million, a price-to-earnings ratio of -1.62 and a beta of 3.18. NeurAxis, Inc. has a 12-month low of $1.33 and a 12-month high of $6.20. The stock’s 50 day simple moving average is $2.62 and its 200 day simple moving average is $2.47.

About NeurAxis

NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.